The making and the breaking of senescence: Changes of gene expression during cellular aging and immortalization

Experimental Gerontology

Volumn 33, Issue 4, 1998, Pages 291-301

  Jansen Dürr, Pidder ^a,b  

^a Inst f Biomed Alternsforschung   (Austria)

^b ERICH SCHMID INSTITUTE OF MATERIALS SCIENCE   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN D1; CYCLIN DEPENDENT KINASE; CYCLIN E; ONCOPROTEIN; PROTEIN P53; REGULATOR PROTEIN; SOMATOMEDIN BINDING PROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR E2F;

CELL AGING; CELL CYCLE; CELL IMMORTALIZATION; FIBROBLAST; GENE EXPRESSION; HUMAN; NONHUMAN; PRIORITY JOURNAL; REVIEW; SENESCENCE; TELOMERE; WART VIRUS;

AGING; CELL AGING; CELL CYCLE; CELL LINE, TRANSFORMED; FIBROBLASTS; GENE EXPRESSION; GENES, REGULATOR; GROWTH SUBSTANCES; HUMANS; PAPILLOMAVIRIDAE; TELOMERE;

HUMAN PAPILLOMAVIRUS TYPES;

EID: 0032104625     PISSN: 05315565     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0531-5565(98)00006-0     Document Type: Review

References (103)

1. ADLER, M.J., CORONEL, C., SHELTON, E., SEEGMILLER, J.E., and DEWJI, N.N. Increased gene expression of Alzheimer disease beta-amyloid precursor protein in senescent cultured fibroblasts. Proc. Natl. Acad. Sci. USA 88, 16-20, 1991.
2. AFSHARI, C.A., NICHOLS, M.A., XIONG, Y., and MUDRYJ, M. A role for a p21-E2F interaction during senescence arrest of normal human fibroblasts. Cell Growth Different. 7, 979-988, 1996.
3. ATADJA, P., WONG, H., GARKAVTSEV, I., VEILLETTE, C., and RIABOWOL, K. Increased activity of p53 in senescing fibroblasts. Proc. Natl. Acad. Sci. USA 92, 8348-8352, 1995.
4. BEIJERSBERGEN, R.L. and BERNARDS, R. Cell cycle regulation by the retinoblastoma family of growth inhibitory proteins. Biochim. Biophys. Acta Rev. Cancer 1287, 103-120, 1996.
5. BELAIR, C.D., YEAGER, T.R., LOPEZ, P.M., and REZNIKOFF, C.A. Telomerase activity: A biomarker of cell proliferation, not malignant transformation. Proc. Natl. Acad. Sci. USA 94, 13677-13682, 1997.
6. BODNAR, A., OUELLETTE, M., HOLT, M., CHIU, C., MORIN, G., HARLEY, C., SHAY, J., LICHTSTEINER, S., and WRIGHT, W. Extension of life-span by introduction of telomerase into normal human cells. Science 279, 349-353, 1998.
7. BOND, J., HAUGHTON, M., BLAYDES, J., GIRE, V., WYNFORD, T.D., and WYLLIE, F. Evidence that transcriptional activation by p53 plays a direct role in the induction of cellular senescence. Oncogene 13, 2097-2104, 1996.
8. BOYER, S.N., WAZER, D.E., and BAND, V. E7 protein of human papilloma virus-16 induces degradation of retinoblastoma protein through the ubiquitin-proteasome pathway. Cancer Res. 56, 4620-4624, 1996.
9. BROWN, J.P., WEI, W.Y., and SEDIVY, J.M. Bypass of senescence after disruption of p21(CIP1/WAF1) gene in normal diploid human fibroblasts. Science 277, 831-834, 1997.
10. BRYAN, T.M., ENGLEZOU, A., DALLA, P.L., DUNHAM, M.A., and REDDEL, R.R. Evidence for an alternative mechanism for maintaining telomere length in human tumors and tumor-derived cell lines. Nat. Med. 3, 1271-1274, 1997.
11. BUCKBINDER, L., TALBOTT, R., VELASCOMIGUEL, S., TAKENAKA, I., FAHA, B., SEIZINGER, B.R., and KLEY, N. Induction of the growth inhibitor IGF-binding protein 3 by p53. Nature 377, 646-649, 1995.
12. CHEN, J.J., REID, C.E., BAND, V., and ANDROPHY, E.J. Interaction of papillomavirus E6 oncoproteins with a putative calcium-binding protein. Science 269, 529-531, 1995.
13. CHEN, K.Y., CHANG, Z.F., PANG, J.H., HE, G.S., and LIU, A.Y. Polyamine metabolism and cell-cycle-dependent gene expression in IMR-90 human diploid fibroblasts during senescence in culture. Exp. Gerontol. 24, 523-537, 1989.
14. CHIN, J.H., OKAZAKI, M., FRAZIER, J.S., HU, Z.W., and HOFFMAN, B.B. Impaired cAMP-mediated gene expression and decreased cAMP response element binding protein in senescent cells. Am. J. Physiol. 271, c362-c371, 1996.
15. CHOI, A.M., OLSEN, D.R., COOK, K.G., DEAMOND, S.F., UITTO, J., and BRUCE, S.A. Differential extracellular matrix gene expression by fibroblasts during their proliferative life span in vitro and at senescence. J. Cell Physiol. 151, 147-155, 1992.
16. COMI, P., CHIARAMONTE, R., and MAIER, J.A. Senescence-dependent regulation of type 1 plasminogen activator inhibitor in human vascular endothelial cells. Exp. Cell Res. 219, 304-308, 1995.
17. COUNTER, C.M., BOTELHO, F.M., WANG, P., HARLEY, C.B., and BACCHETTI, S. Stabilization of short telomeres and telomerase activity accompany immortalization of Epstein-Barr virus-transformed human B lymphocytes. J. Virol. 68, 3410-3414, 1994.
18. DIMRI, G.P., LEE, X., BASILE, G., ACOSTA, M., SCOTT, G., ROSKELLEY, C., MEDRANO, E.E., LINSKENS, M., RUBELJ, I., PEREIRA, S.O., et al. A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc. Natl. Acad. Sci. USA 92, 9363-9367, 1995.
19. DOGGETT, D.L., ROTENBERG, M.O., PIGNOLO, R.J., PHILLIPS, P.D., and CRISTOFALO, V.J. Differential gene expression between young and senescent, quiescent WI-38 cells. Mech Ageing Dev. 65, 239-255, 1992.
20. DULIC, V., DRULLINGER, L.F., LEES, E., REED, S.I., and STEIN, G.H. Altered regulation of G(1)-cyclins in senescent human diploid fibroblasts - accumulation of inactive cyclin-E-Cdk2 and cyclin-D1-Cdk2 complexes. Proc. Natl. Acad. Sci. USA 90, 11034-11038, 1993.
21. DURO, D., BERNARD, O., DELLAVALLE, V., BERGER, R., and LARSEN, C.J. A new type of p16(INK4)/MTS1 gene transcript expressed in B-cell malignancies. Oncogene 11, 21-29, 1995.
22. DÜRST, M., DZARLIEVA-PETRUSEVSKA, R.T., BOUKAMP, P., FUSENIG, N.E., and GISSMANN, L. Molecular and cytogenetic analysis of immortalized primary human keratinocytes obtained after transfection with human papillomavirus type 16 DNA. Oncogene 1, 251-256, 1987.
23. DYSON, N., HOWLEY, P.M., MUNGER, K., and HARLOW, E. The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product. Science 243, 934-937, 1989.
24. EL-DEIRY, W.S., TOKINO, T., VELCULESCU, V.E., LEVY, D.B., PARSONS, R., TRENT, J.M., LIN, D., MERCER, W.E., KINZLER, K.W., and VOGELSTEIN, B. WAF1, a potential mediator of p53 tumor suppression. Cell 75, 817-825, 1993.
25. FONTIJN, R., HOP, C., BRINKMAN, H.J., SLATER, R., WESTERVELD, A., VANMOURIK, J.A., and PANNEKOEK, H. Maintenance of vascular endothelial cell-specific properties after immortalization with an amphotrophic replication-deficient retrovirus containing human papilloma virus 16 E6/E7 DNA. Exp. Cell Res. 216, 199-207, 1995.
26. FUKAMI, J., ANNO, K., UEDA, K., TAKAHASHI, T., and IDE, T. Enhanced expression of cyclin D1 in senescent human fibroblasts. Mech Ageing Dev. 81, 139-157, 1995.
27. FUNK, J., WAGA, S., HARRY, J., ESPLING, E., STILLMAN, B., and GALLOWAY, D. Inhibition of cdk activity and PCNA-dependent DNA replication by p21 is blocked by interaction with the HPV-16 E7 oncoprotein. Genes Dev. 11, 2090-2100, 1997.
28. GALLOWAY, D.A. and MCDOUGALL, J.K. The disruption of cell cycle checkpoints by papillomavirus oncoproteins contributes to anogenital neoplasia. Semin. Cancer Biol. 7, 309-315, 1996.
29. GARKAVTSEV, I., GRIGORIAN, I., OSSOVSKAYA, V., CHERNOV, M., CHUMAKOV, P., and GUDKOV, A. The candidate tumour suppressor p33ING1 cooperates with p53 in cell growth control. Nature 391, 295-298, 1998.
30. GARKAVTSEV, I., KAZAROV, A., GUDKOV, A., and RIABOWOL, K. Suppression of the novel growth inhibitor p33ING1 promotes neoplastic transformation. Nat. Genet. 14, 415-420, 1996.
31. GARKAVTSEV, I. and RIABOWOL, K. Extension of the replicative life span of human diploid fibroblasts by inhibition of the p33ING1 candidate tumor suppressor. Mol. Cell Biol. 17, 2014-2019, 1997.
32. GOLDSTEIN, S., MOERMAN, E.J., and BAXTER, R.C. Accumulation of insulin-like growth factor binding protein-3 in conditioned medium of human fibroblasts increases with chronologic age of donor and senescence in vitro. J. Cell Physiol. 156, 294-302, 1993.
33. GOLDSTEIN, S., MOERMAN, E.J., JONES, R.A., and BAXTER, R.C. Insulin-like growth factor binding protein 3 accumulates to high levels in culture medium of senescent and quiescent human fibroblasts. Proc. Natl. Acad. Sci. USA 88, 9680-9684, 1991.
34. GOOD, L., DIMRI, G.P., CAMPISI, J., and CHEN, K.Y. Regulation of dihydrofolate reductase gene expression and E2F components in human diploid fibroblasts during growth and senescence. J. Cell Physiol. 168, 580-588, 1996.
35. GOODMAN, L. and STEIN, G.H. Basal and induced amounts of interleukin-6 mRNA decline progressively with age in human fibroblasts. J. Biol. Chem. 269, 19250-19255, 1994.
36. GRIGORIEV, V.G., MOERMAN, E.J., and GOLDSTEIN, S. Senescence and cell density of human diploid fibroblasts influence metabolism of insulin-like growth factor binding proteins. J. Cell Physiol. 160, 203-211, 1994.
37. GRIGORIEV, V.G., MOERMAN, E.J., and GOLDSTEIN, S. Overexpression of insulin-like growth factor binding protein-3 by senescent human fibroblasts: Attenuation of the mitogenic response to IGF-I. Exp. Cell Res. 219, 315-321, 1995.
38. HABER, D.A. Splicing into senescence: The curious case of p16 and p19ARF. Cell 91, 555-558, 1997.
39. HARA, E., SMITH, R., PARRY, D., TAHARA, H., STONE, S., and PETERS, G. Regulation of p16CDKN2 expression and its implications for cell immortalization and senescence. Mol. Cell Biol. 16, 859-867, 1996.
40. HAWLEY-NELSON, P., VOUSDEN, K.H., HUBBERT, N.L., LOWY, D.R., and SCHILLER, J.T. HPV16 E6 and E7 proteins cooperate to immortalize human foreskin keratinocytes. EMBO J. 8, 3905-3910, 1989.
41. HELENIUS, M., HANNINEN, M., LEHTINEN, S.K., and SALMINEN, A. Changes associated with aging and replicative senescence in the regulation of transcription factor nuclear factor-kappa B. Biochem. J. 318, 603-608, 1996.
42. HUIBREGTSE, J.M., SCHEFFNER, M., and HOWLEY, P.M. Cloning and expression of the cDNA for E6-AP, a protein that mediates the interaction of the human papillomavirus E6 oncoprotein with p53. Mol. Cell Biol. 13, 775-784, 1993.
43. JANSEN-DÜRR, P. How viral oncogenes make the cell cycle. Trends Genet. 12, 270-275, 1996.
44. JOHNSON, M., DIMITROV, D., VOJTA, P.J., BARRETT, J.C., NODA, A., PEREIRA, S.O., and SMITH, J.R. Evidence for a p53-independent pathway for upregulation of SDI1/CIP1/WAF1/p21 RNA in human cells. Mol. Carcinog. 11, 59-64, 1994.
45. JONES, D.L., ALANI, R.M., and MÜNGER, K. The human papillomavirus E7 oncoprotein can uncouple cellular differentiation and proliferation in human keratinocytes by abrogating p21CIP1-mediated inhibition of cdk2. Genes Dev. 11, 2101-2111, 1997.
46. KAMIJO, T., ZINDY, F., ROUSSEL, M.F., QUELLE, D.E., DOWNING, J.R., ASHMUN, R.A., GROSVELD, G., and SHERR, C.J. Tumor suppression at the mouse INK4a locus mediated by the alternative reading frame product p19ARF. Cell 91, 649-659, 1997.
47. KANAZAWA, S., FUJIWARA, Y., and MIZUNO, K. Selective repression of growth-regulating cdk2, cyclin E and E2F1 genes in human cell senescence. Kobe J. Med. Sci. 40, 165-174, 1994.
48. KATO, M.V., SATO, H., TSUKADA, T., IKAWA, Y., AIZAWA, S., and NAGAYOSHI, M. A follistatin-like gene, mac25, may act as a growth suppressor of osteosarcoma cells. Oncogene 12, 1361-1364, 1996.
49. KLINGELHUTZ, A.J., FOSTER, S.A., and MCDOUGALL, J.K. Telomerase activation by the E6 gene product of human papillomavirus type 16. Nature 380, 79-82, 1996.
50. KODAMA, S., YAMADA, H., ANNAB, L., and BARRETT, J.C. Elevated expression of mitochondrial cytochrome b and NADH dehydrogenase subunit 4/4L genes in senescent human cells. Exp. Cell Res. 219, 82-86, 1995.
51. KURO, O.M., MATSUMURA, Y., AIZAWA, H., KAWAGUCHI, H., SUGA, T., UTSUGI, T., OHYAMA, Y., KURABAYASHI, M., KANAME, T., KUME, E., IWASAKI, H., IIDA, A., SHIRAKI, I.T., NISHIKAWA, S., NAGAI, R., and NABESHIMA, Y.I. Mutation of the mouse klotho gene leads to a syndrome resembling ageing. Nature 390, 45-51, 1997.
52. LATHANGUE, N.B. E2F and the molecular mechanisms of early cell-cycle control. Biochem. Soc. Transact. 24, 54-59, 1996.
53. LEE, X., SI, S.P., TSOU, H.C., and PEACOCKE, M. Cellular aging and transformation suppression: A role for retinoic acid receptor beta 2. Exp. Cell Res. 218, 296-304, 1995.
54. LEES, E. Cyclin dependent kinase regulation. Curr. Opin. Cell Biol. 7, 773-780, 1995.
55. LEPOOLE, I.C., VANDENBERG, F.M., VANDENWIJNGAARD, R.M.J.G.J., GALLOWAY, D.A., VANAMSTEL, P.J., BUFFING, A.A.M., SMITS, H.L., WESTERHOF, W., and DAS, P.K. Generation of a human melanocyte cell line by introduction of HPV16 E6 and E7 genes. In Vitro Cell. Dev. Biol. Anim. 33, 42-49, 1997.
56. LOUGHRAN, O., MALLIRI, A., OWENS, D., GALLIMORE, P.H., STANLEY, M.A., OZANNE, B., FRAME, M.C., and PARKINSON, E.K. Association of CDKN2A/p16INK4A with human head and neck keratinocyte replicative senescence: Relationship of dysfunction to immortality and neoplasia. Oncogene 13, 561-568, 1996.
57. LUCE, M.C. and CRISTOFALO, V.J. Reduction in heat shock gene expression correlates with increased thermosensitivity in senescent human fibroblasts. Exp. Cell Res. 202, 9-16, 1992.
58. LUCIBELLO, F.C., SEWING, A., BRUSSELBACH, S., BURGER, C., and MULLER, R. Deregulation of cyclin-D1 and cyclin-E and suppression of cdk2 and cdk4 in senescent human fibroblasts. J. Cell Sci. 105, 123-133, 1993.
59. MEDCALF, A.S.C., KLEINSZANTO, A.J.P., and CRISTOFALO, V.J. Expression of p21 is not required for senescence of human fibroblasts. Cancer Res. 56, 4582-4585, 1996.
60. MEYERSON, M., COUNTER, C.M., EATON, E.N., ELLISEN, L.W., STEINER, P., CADDLE, S.D., ZIAUGRA, L., BEIJERSBERGEN, R.L., DAVIDOFF, M.J., LIU, Q., BACCHETTI, S., HABER, D.A., and WEINBERG, R.A. hEST2, the putative human telomerase catalytic subunit gene, is up-regulated in tumor cells and during immortalization. Cell 90, 785-795, 1997.
61. MILLIS, A.J., MCCUE, H.M., KUMAR, S., and BAGLIONI, C. Metalloproteinase and TIMP-1 gene expression during replicative senescence. Exp. Gerontol. 27, 425-428, 1992.
62. MOERMAN, E.J., THWEATT, R., MOERMAN, A.M., JONES, R.A., and GOLDSTEIN, S. Insulin-like growth factor binding protein-3 is overexpressed in senescent and quiescent human fibroblasts. Exp. Gerontol. 28, 361-370, 1993.
63. MÜNGER, K., PHELPS, W.C., BUBB, V., HOWLEY, P.M., and SCHLEGEL, R. The E6 and E7 genes of human papillomavirus type 16 together are necessary and sufficient for transformation of primary human Keratinocytes. J. Virol. 63, 4417-4421, 1989.
64. NAKAMURA, T.M., MORIN, G.B., CHAPMAN, K.B., WEINRICH, S.L., ANDREWS, W.H., LINGNER, J., HARLEY, C.B., and CECH, T.R. Telomerase catalytic subunit homologs from fission yeast and human. Science 277, 955-959, 1997.
65. OH, Y., MULLER, H., NG, L., and ROSENFELD, R. TGF-β-induced cell growth inhibition in human breast cancer cells is mediated through insulin-like growth factor-binding protein-3 action. J. Biol. Chem. 270, 13589-13592, 1995.
66. OH, Y., NAGALLA, S.R., YAMANAKA, Y., KIM, H.S., WILSON, E., and ROSENFELD, R.G. Synthesis and characterization of insulin-like growth factor-binding protein (IGFBP)-7. Recombinant human mac25 protein specifically binds IGF-I and -II. J. Biol. Chem. 271, 30322-30325, 1996.
67. OHTSUBO, M., THEODORAS, A.M., SCHUMACHER, J., ROBERTS, J.M., and PAGANO, M. Human cyclin E, a nuclear protein essential for the G(1)-to-S phase transition. Mol. Cell. Biol. 15, 2612-2624, 1995.
68. PANG, J.H. and CHEN, K.Y. A specific CCAAT-binding protein, CBP/tk, may be involved in the regulation of thymidine kinase gene expression in human EMR-90 diploid fibroblasts during senescence. J. Biol. Chem. 268, 2909-2916, 1993.
69. PANG, J.H. and CHEN, K.Y. Global change of gene expression at late G1/S boundary may occur in human IMR-90 diploid fibroblasts during senescence. J. Cell Physiol. 160, 531-538, 1994.
70. QUELLE, D.E., ZINDY, F., ASHMUN, R.A., and SHERR, C.J. Alternative reading frames of the INK4a tumor suppressor gene encode two unrelated proteins capable of inducing cell cycle arrest. Cell 83, 993-1000, 1995.
71. RAJAH, R., VALENTINIS, B., and COHEN, P. Insulin like growth factor (IGF)-binding protein-3 induces apoptosis and mediates the effects of transforming growth factor-beta 1 on programmed cell death through a p53-and IGF-independent mechanism. J. Biol. Chem. 272, 12181-12188, 1997.
72. REED, S.I., BAILLY, E., DULIC, V., HENGST, L., RESNITZKY, D., and SLINGERLAND, J. G(1) control in mammalian cells. J. Cell Sci. 18(Suppl.), 69-73, 1994.
73. RESNITZKY, D., GOSSEN, M., BUJARD, H., and REED, S.I. Acceleration of the G(1)/S phase transition by expression of cyclins D1 and E with an inducible system. Mol. Cell. Biol. 14, 1669-1679, 1994.
74. REZNIKOFF, C.A., BELAIR, C., SAVELIEVA, E., ZHAI, Y., PFEIFER, K., YEAGER, T., THOMPSON, K.J., DEVRIES, S., BINDLEY, C., NEWTON, M.A., SEKHON, G., and WALDMAN, F. Long-term genome stability and minimal genotypic and phenotypic alterations in HPV16 E7-, but not E6-, immortalized human uroepithelial cells. Genes Dev. 8, 2227-2240, 1994.
75. REZNIKOFF, C.A., YEAGER, T.R., BELAIR, C.D., SAVELIEVA, E., PUTHENVEETTIL, J.A., and STADLER, W.M. Elevated p16 at senescence and loss of p16 at immortalization in human papillomavirus 16 E6, but not E7, transformed human uroepithelial cells. Cancer Res. 56, 2886-2890, 1996.
76. RIABOWOL, K.T. Transcription factor activity during cellular aging of human diploid fibroblasts. Biochem. Cell Biol. 70, 1064-1072, 1992.
77. RICHTER, K.H., AFSHARI, C.A., ANNAB, L.A., BURKHART, B.A., OWEN, R.D., BOYD, J., and BARRETT, J.C. Down-regulation of cdc2 in senescent human and hamster cells. Cancer Res. 51, 6010-6013, 1991.
78. ROCKWELL, G.A., JOHNSON, G., and SIBATANI, A. In vitro senescence of human keratinocyte cultures. Cell Struct. Funct. 12, 539-548, 1987.
79. RUBIN, H. Cell aging in vivo and in vitro. Mech Ageing Dev. 98, 1-35, 1997.
80. SAUNDERS, N.A., SMITH, R.J., and JETTEN, A.M. Regulation of proliferation-specific and differentiation-specific genes during senescence of human epidermal keratinocyte and mammary epithelial cells. Biochem. Biophys. Res. Commun. 197, 46-54, 1993.
81. SCHEFFNER, M., HUIBREGTSE, J.M., and HOWLEY, P.M. Identification of a human ubiquitin-conjugating enzyme that mediates the E6-AP-dependent ubiquitination of p53. Proc. Natl. Acad. Sci. USA 91, 8797-8801, 1994.
82. SCHEFFNER, M., WERNESS, B.A., HUIBREGTSE, J.M., LEVINE, A.J., and HOWLEY, P.M. The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell 63, 1129-1136, 1990.
83. SERRANO, M., LEE, H., CHIN, L., CORDON, C.C., BEACH, D., and DEPINHO, R.A. Role of the INK4a locus in tumor suppression and cell mortality. Cell 85, 27-37, 1996.
84. SHAY, J.W. Telomerase in human development and cancer. J. Cell Physiol. 173, 266-270, 1997.
85. SHAY, J.W. and WRIGHT, W.E. Telomerase activity in human cancer. Curr. Opin. Oncol. 8, 66-71, 1996.
86. STANBRIDGE, E.J. Functional evidence for human tumour suppressor genes: Chromosome and molecular genetic studies. Cancer Surv. 12, 5-24, 1992.
87. STEIN, G.H. and DULIC, V. Origins of G(1) arrest in senescent human fibroblasts. Bioessays 17, 537-543, 1995.
88. SWISSHELM, K., RYAN, K., TSUCHIYA, K., and SAGER, R. Enhanced expression of an insulin growth factor-like binding protein (mac25) in senescent human mammary epithelial cells and induced expression with retinoic acid. Proc. Natl. Acad. Sci. USA 92, 4472-4476, 1995.
89. TAHARA, H., KAMADA, K., SATO, E., TSUYAMA, N., KIM, J.K., HARA, E., ODA, K., and IDE, T. Increase in expression levels of interferon-inducible genes in senescent human diploid fibroblasts and in SV40-transformed human fibroblasts with extended lifespan. Oncogene 11, 1125-1132, 1995a.
90. TAHARA, H., SATO, E., NODA, A., and IDE, T. Increase in expression level of p21(sdi1/cip1/waf1) with increasing division age in both normal and SV4O-transformed human fibroblasts. Oncogene 10, 835-840, 1995b.
91. TOLLEFSBOL, T.O. Gene expression of carbohydrate metabolism in cellular senescence and aging. Mol. Biol. Med. 4, 251-263, 1987.
92. VAZIRI, H. and BENCHIMOL, S. From telomere loss to p53 induction and activation of a DNA-damage pathway at senescence: The telomere loss/DNA damage model of cell aging. Exp. Gerontol. 31, 295-301, 1996.
93. VAZIRI, H., WEST, M.D., ALLSOPP, R.C., DAVISON, T.S., WU, Y.S., ARROWSMITH, C.H., POIRIER, G.G., and BENCHIMOL, S. ATM-dependent telomere loss in aging human diploid fibroblasts and DNA damage lead to the post-translational activation of p53 protein involving poly(ADP-ribose) polymerase. Embo J. 16, 6018-6033, 1997.
94. WANG, E. Senescent human fibroblasts resist programmed cell death, and failure to suppress bcl2 is involved. Cancer Res. 55, 2284-2292, 1995.
95. WANG, E. Regulation of apoptosis resistance and ontogeny of age-dependent diseases. Exp. Gerontol. 32, 471-484, 1997.
96. WARNER, H.R., HODES, R.J., and POCINKI, K. What does cell death have to do with aging? J. Am. Geriatr. Soc. 45, 1140-1146, 1997.
97. WAZER, D.E., LIU, X.L., CHU, Q., GAO, Q., and BAND, V. Immortalization of distinct human mammary epithelial cell types by human papilloma virus 16 E6 or E7. Proc. Natl. Acad. Sci. USA 92, 3687-3691, 1995.
98. WON, K.-A., XIONG, Y., BEACH, D., and GILMAN, M.Z. Growth-regulated expression of D-type cyclin genes in human diploid fibroblasts. Proc. Natl. Acad. Sci. USA 89, 9910-9914, 1992.
99. WRIGHT, W.E., PIATYSZEK, M.A., RAINEY, W.E., BYRD, W., and SHAY, J.W. Telomerase activity in human germline and embryonic tissues and cells. Dev. Genet. 18, 173-179, 1996.
100. YANG, L.Q., DIDENKO, V.V., NODA, A., BILYEU, T.A., DARLINGTON, G.J., SMITH, J.R., and HORNSBY, P.J. Increased expression of p21(Sdi1) in adrenocortical cells when they are placed in culture. Exp. Cell Res. 221, 126-131, 1995.
101. ZERFASS-THOME, K., ZWERSCHKE, W., MANNHARDT, B., TINDLE, R., BOTZ, J., and JANSEN-DÜRR, P. Inactivation of the cdk inhibitor p27KIP1 by the human papillomavirus type 16 E7 oncoprotein. Oncogene 13, 2323-2330, 1996.
102. ZUR HAUSEN, H. Human papillomaviruses in the pathogenesis of anogenital cancer. Virology 184, 9-13, 1991.
103. ZUR HAUSEN, H. and SCHNEIDER, A. The role of papillomaviruses in human anogenital cancer. In: The Papovaviridae: The Papillomaviruses, Howley, P.M. and Salzman, N. (Editors), pp. 245-263, Plenum, New York.